Document is current

Article History

Received: 20 October 2021

Accepted: 25 May 2022

First Online: 8 June 2022

Declarations

:

: Ethical approval was obtained from the Australian Institute of Health and Welfare (AIHW) (reference, EO2018/1/418) and University of South Australia (reference, 200489) Human Research Ethics Committees. The AIHW and the University of South Australia Human Research Ethics Committees approved a waiver of written informed consent for individuals whose retrospective data is included in this study for reasons outlined in paragraph 2.3.10 of the <i>National Statement on Ethical Conduct in Human Research 2007 (Updated 2018)</i> (e.g., low risk nature of the research, benefits outweigh any risk of harm, it is impracticable to obtain consent for all individuals, there is no likely reasons that participants would not have consented if asked, data are de-identified and protected, results have significance for health and welfare). The waiver of consent for this study was applied in accordance with paragraph 2.3.10 of the <i>National Statement on Ethical Conduct in Human Research 2007 (Updated 2018)</i> and all conditions for the waiver of the requirement for consent under paragraph 2.3.10 have been strictly adhered to. Access to the de-identified, individual-level linked data used in this study was only permitted to research personnel with relevant approvals under Sect. 29 of the <i>Australian Institute of Health and Welfare Act 1987, The Privacy Act 1988 (Part III),</i> including the Australian Privacy Principles and project-specific data access and confidentiality agreements. The authors confirm the research was performed in accordance with relevant guidelines/regulations.

: Not applicable.

: This analysis was funded by the Australian Association of Consultant Pharmacy (AACP), an Australian organization that accredits pharmacists to provide residential medication management reviews. JKS, SC, SJ, and AS are registered pharmacists and accredited by the AACP to perform residential medication management reviews (RMMRs). GM is the Chief Executive Officer of the AACP. SC and SJ are Non-Executive Directors of the AACP. AS is a member of the AACP National Advisory Group. There are no other competing interests to declare.